Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
216 results about "Muscle mass" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Hydrogels for vocal cord and soft tissue augmentation and repair
ActiveUS20100055184A1Repairing pliabilityDiminished functional vibratory capacityBiocideOrganic active ingredientsEpitheliumBreast implant
The present invention provides hydrogels and compositions thereof for vocal cord repair or augmentation, as well as other soft tissue repair or augmentation (e.g., bladder neck augmentation, dermal fillers, breast implants, intervertebral disks, muscle-mass). The hydrogels or compositions thereof are injected into the superficial lamina propria or phonatory epithelium to restore the phonatory mucosa of the vocal cords, thereby restoring a patient's voice. In particular, it has been discovered that hydrogels with an elastic shear modulus of approximately 25 Pa are useful in restoring the pliability of the phonatory mucosa. The invention also provides methods of preparing and using the inventive hydrogels.
Owner:MASSACHUSETTS INST OF TECH
Pharmaceutical compositions
ActiveUS8268806B2Achieve beneficial effectAvoid their undesirable side effectOrganic active ingredientsMuscular disorderEstrogenic EffectsInsulin resistance
Owner:MYRIEL PHARM LLC
Nutritional composition and method for improving protein deposition
Compositions and methods that stimulate body protein synthesis and can improve muscle mass maintenance and recovery are provided. The composition comprises (i) a protein source which provides at least about 8% total calories of the composition and which includes at least about 50% by weight of whey protein; (ii) a lipid source having an omega 3:6 fatty acid ratio of about 5:1 to about 10:1 and which provides at least about 18% total calories of the composition; (iii) a carbohydrate source; and (iv) a balanced macronutrient profile comprising at least vitamin E and vitamin C.
Owner:NESTEC SA
Method for treating ALS via the increased production of factor h
InactiveUS20140234275A1Improve satisfactionInhibition effectBiocideOrganic active ingredientsWhole bodyPrimary motor neuron
Methods and systems for the treatment for ALS incorporating stem cells harvested from the subject to be treated. These stem cells may be genetically altered with the addition of several genes of interest. Then, the patient will receive systemic gene therapy for the muscles and directed specifically at motor neurons. In this multi-pronged treatment approach, the stem cells provide immune regulation and the regeneration of motor neurons. And, the new motor neurons carry the added genes, which are protective against motor neuron death from ALS. The systemic therapy increases the amount of genes, which further reduces the effects of ALS. Additional gene therapy administered in the muscle will be further protective of the axon, while maintaining muscle mass and function.
Owner:BIOVIVA USA
Compositions for Preventing and Reducing Delayed Onset Muscle Soreness
InactiveUS20080317886A1Inhibit inflammationSpeed up recoveryBiocideSugar food ingredientsSucroseL glutamate
The present invention relates to the compositions that enhance post-exercise recovery processes to increase both strength and muscle mass, replace glycogen stores, and prevent inflammation, resulting in the prevention and / or reduction of delayed onset muscle soreness. Additionally, it provides a feeling of muscle relaxation as well as a feeling of mental tranquility immediately following exercise. The composition consists of any or all high-glycemic sugars and / or polysaccharides (e.g., sucrose, glucose, maltodextrin), all essential amino acids and beta-hydroxy-beta-methylbutyrate and can include other amino acids sources (e.g. whey protein), performance enhancing agents (e.g., caffeine, L-glutamate), anti-inflammatory agents (e.g., ginger, boswellia, curcumen), antioxidants (vitamin C, vitamin E, selenium, polyphenols,), insulin-mimicking agents (cinnamon, Banaba), analgesics (e.g. aspirin, ibuprofen, naproxen, acetaminophen), and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.
Owner:SOUTHWEST IMMUNOLOGY
Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders
ActiveUS20120164243A1Increase and maintain metabolic rateImprove and maintain mental performanceBiocideNervous disorderPhysiologyUrolithin
Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and / or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
Owner:AMAZENTIS
Composition for enhancing cellular energy
InactiveUS20060292134A1Improve bioavailabilityIncreasing subject 's relative intensityBiocidePeptide/protein ingredientsPhysical medicine and rehabilitationArginine
A composition for enhancing cellular energy that includes creatine, L-arginine-α-ketoglutarate, D-ribose, L-carnitine, L-citrulline, and pyruvate. The composition is administering to a subject to enhance cellular energy, to increase relative intensity of physical activity performed by the subject, to increase endurance of the subject during the physical activity and to increase the muscle mass of the subject.
Owner:ADVOCARE INT
Apparatus and method to treat heart disease using lasers to form microchannels
InactiveUS20060122584A1Increasing revascularizationPreserving abilityCatheterSurgical instrument detailsIschemic heartActive agent
Methods and devices for increasing revascularization in an ischemic heart and for reducing muscle mass or volume in congestive heart failure patients are described. The method includes using laser energy to create microchannels in the target tissue. The microchannels are separated from each other to maintain tissue that is untreated or undamaged by laser energy. Such undamaged tissue augments angiogenesis. The method also includes delivery of bioactive agents that are angiogenic. The apparatus simultaneously creates a plurality of microchannels that are separated from each other and thereby promote angiogenesis, revascularization and / or muscle reduction.
Owner:RELIANT TECH INC
Method and device for measuring body composition
InactiveCN1489447AHigh precisionCorrect feature deviationDiagnostic recording/measuringSensorsProximal pointRegression analysis
To accurately measure the muscle mass, body-fat ratio and / or other information of the subject, the human body is divided into nine segments including the trunk, right and left forearms, right and left upper arms, right and left thigh, and right and left crura. Four distal voltage-measuring points Pv are determined at the wrists and ankles, and four proximal voltage-measuring points Pv are determined at the elbows and knees. Four current-carrying electrodes and four measuring electrodes are used. First, the measuring electrodes are attached to distal points, and the impedances of four limbs and the trunk are measured. Then, the measuring electrodes are moved to proximal points, and the impedances of four limbs and the trunk are measured. From the measurement result, the measurement value is calculated for each segment. Then, using estimation formulae created by a regression analysis based on the data collected with an MRI, the body composition such as a muscle mass is estimated from the measurement values of the impedances and body specific information including the height, weight, etc.
Owner:フィジオン
Heterocyclic aromatic compounds useful as growth hormone secretagogues
Novel heterocyclic aromatic compounds are provided that are useful in stimulating endogenous production or release of growth hormone, said compounds having the general structure of formula I wherein R1, R1a, R6, Xa, Xb and Y are as described herein. The compounds provided herein are useful in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength.
Owner:BRISTOL MYERS SQUIBB CO
Modulation of myostatin and use thereof in cell transplantation-based treatment of muscle disease
InactiveUS20060251632A1Improve fusionIncreased proliferationBiocideAnimal repellantsMyostatinDisease
Owner:UNIV LAVAL
Exercise aid device
InactiveUS7942783B2Reduce the burden onEfficiently provideClubsPerson identificationTrochanter majorKnee Joint
An exercise aid device has a hip supporting member movable relative to a base, footrests movable relative to the base, drive means for driving the hip supporting member, body constitution estimating unit for estimating at least one of fat mass and muscle mass of a user, and a controller for the drive means. The controller controls the drive means such that a load acting on a femoral region by own weight of the user supported on the hip supporting member changes according to a relative positional displacement between the user's toe and trochanter major, the positional displacement is allowed in a direction of flexion and extension of knee joint of the user, and an angle of the knee joint is maintained substantially constant. In addition, since the controller controls the drive means by use of an output of the body constitution estimating unit, it is possible to provide an exercise with less burden to the knee joint and a suitable strength for the user.
Owner:MATSUSHITA ELECTRIC WORKS LTD
Methods for Enhancing the Quality of Life of a Senior Animal
Methods for enhancing the quality of life of a senior or super senior animal by feeding the animal a composition comprising at least one omega-3 polyunsaturated fatty acid and various combinations of amino acids, minerals, and antioxidants in amounts effective to enhance alertness, improve vitality, protect cartilage, maintain muscle mass, enhance digestibility, and improve skin and pelage quality. Changes in expression of genes associated with several biological pathways induced in an animal by feeding it said composition are consistent with an enhanced quality of life.
Owner:HILLS PET NUTRITION INC
Exercise Aid Device
InactiveUS20080312040A1Reduce the burden onEfficiently provideClubsPerson identificationTrochanter majorKnee Joint
An exercise aid device has a hip supporting member movable relative to a base, footrests movable relative to the base, drive means for driving the hip supporting member, body constitution estimating unit for estimating at least one of fat mass and muscle mass of a user, and a controller for the drive means. The controller controls the drive means such that a load acting on a femoral region by own weight of the user supported on the hip supporting member changes according to a relative positional displacement between the user's toe and trochanter major, the positional displacement is allowed in a direction of flexion and extension of knee joint of the user, and an angle of the knee joint is maintained substantially constant. In addition, since the controller controls the drive means by use of an output of the body constitution estimating unit, it is possible to provide an exercise with less burden to the knee joint and a suitable strength for the user.
Owner:MATSUSHITA ELECTRIC WORKS LTD
Composition for enhancing cellular energy
InactiveUS7645742B2Increase ease of administration and bioavailabilityIncreasing subject 's relative intensityBiocidePeptide/protein ingredientsPhysical medicine and rehabilitationPyruvic acid
Owner:ADVOCARE INT
Treatment of Duchenne muscular dystrophy with myoblasts expressing dystrophin and treated to block myostatin signaling
InactiveUS7887793B2Increased proliferationQuality improvementBiocideAnimal repellantsMyostatinDisease
Owner:UNIV LAVAL
Oligomers
InactiveUS20130085139A1Improve securityLasting effectOrganic active ingredientsSplicing alterationMyostatinPrecursor mRNA
Certain disclosed oligomers induce exon skipping during processing of myostatin pre-mRNA. The oligomers may be in a vector or encoded by the vector. The vector is used for inducing exon skipping during processing of myostatin pre-mRNA. A therapeutically effective amount of the oligomer may be administered to a subject patient such that exon skipping during processing of myostatin pre-mRNA is induced. The administration to a subject may be used in order to increase or maintain muscle mass, or slowing degeneration of muscle mass in the subject. The administration to a subject may ameliorate muscle wasting conditions, such as muscular dystrophy. Examples of such muscular dystrophies which may be so treated include Becker's muscular dystrophy, congenital muscular dystrophy, Duchenne muscular dystrophy, distal muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy (FSHD), limb-girdle muscular dystrophy, myotonic muscular dystrophy, and oculopharyngeal muscular dystrophy
Owner:ROYAL HOLLOWAY & BEDFORD NEW COLLEGE
Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
Oligomers and polymer compositions are provided which comprise GHB and produce GHB after administration in vivo. Devices for the storage and delivery of these polymers and oligomers are also provided. These oligomers and polymer compositions are useful in a variety of applications. The compositions can be used therapeutically, for example, in the treatment of patients with narcolepsy, chronic schizophrenia, catatonic schizophrenia, atypical psychoses, chronic brain syndrome, neurosis, alcoholism, drug addiction and withdrawal, Parkinson's disease and other neuropharmacological illnesses, hypertension, ischemia, circulatory collapse, radiation exposure, cancer, and myocardial infarction. Other uses for the compositions include anesthesia induction, sedation, growth hormone production, heightened sexual desire, anorectic effects, euphoria, smooth muscle relaxation, muscle mass production, and sleep, including rapid eye movement sleep. In a still further embodiment, the oligomers and polymers may be used to produce absence seizures.
Owner:TEPHA INC
Dietary supplements containing terpenoid acids of maslinic acid or oleanolic acid and process for enhancing muscle mass in mammals
InactiveUS20100204121A1Increasing lean body massQuality improvementBiocidePeptide/protein ingredientsMuscle massMaslinic acid
A process for increasing lean body mass in a mammalian subject is provided that includes administering to the subject a purified quantity of maslinic acid, oleanolic acid, or a combination thereof. The administration can be orally and benefits from ingestion of an amino acid source such as dietary protein, oligopeptides, or amino acids. Administration within 2 hours of muscle-degrading exercise or on a daily basis for a period of time increases lean body mass.
Owner:IN INGREDIENTS
Functional training device
A versatile, functional training device of substantially elliptical shape and comprising a fluid weight that employs principles of unstable resistance as a means of increasing balance, stability, overall strength, core strength and proprioception while increasing lean muscle mass and burning calories. During operation, a user moves the device through a regimen of individualized movements, and the fluid weight moves and shifts inside the device, creating a instability at a point of resistance. The device comprises D-shaped handles with finger grooves adapted for maneuverability. The handles also may be filled with fluid to increase the weight and adaptability of the device across multiple activities and physical regimens. Measuring scales are provided on the device to measure the amount of fluid added to or removed from the device. The device may be transparent or translucent, and the fluid weight may be tinted to aid in visibility.
Owner:MOBIUS ENTERPRISES
Pharmaceutical compositions
ActiveUS20090054383A1Achieve beneficial effectPrevent adverse side effectsBiocideOrganic active ingredientsDiseaseEstrogenic Effects
Novel methods for treating or reducing the likelihood of acquiring symptoms or diseases due to the menopause, in postmenopausal women, particularly osteoporosis, vaginal atrophy and dryness, hypogonadism, diminished libido, skin atrophy, connective tissue disease, urinary incontinence, breast, endometrial, ovarian and uterine cancers, hot flashes, loss of muscle mass, insulin resistance, fatigue, loss of energy, aging, physical symptoms of menopause, in susceptible warm-blooded animals including humans involving administration of a sex steroid precursor are disclosed. Said method comprising novel ways of administering and dosing dehydroepiandrosterone (DHEA) in order to take advantage of positive androgenic effects in the vaginal layers lamina propia and / or the layer muscularis, without undesirably causing systemic estrogenic effects in order to avoid the risk of breast and uterine cancer. Pharmaceutical compositions for delivery of active ingredient(s) useful to the invention are also disclosed.
Owner:MYRIEL PHARM LLC
Rolling, multi-directional fitness device
InactiveUS20180036588A1Muscle strengtheningImprove staminaSpace saving gamesFrictional force resistorsMuscle groupRange of motion
A multi-directional rolling fitness device is disclosed. The device can be used individually or as a pair with either the hands or the feet. The device comprises a handle assembly, which can also comprise a stirrup for the foot, a base unit and a plurality of ball-transfer units. By using a single or pair of these devices, a person can use their body weight to engage in a nearly unlimited number of upper and lower body exercises. The device's ball transfer contact points allow the unit to move in any direction across the floor during exercise repetitions, engaging complex muscle groups, increasing range of motion, and aiding in the development of muscle mass, strength and endurance.
Owner:BROWN LUKE F
Selecting animals for desired genotypic or potential phenotypic properties
InactiveUS20060037090A1Reduced back fatEnhance teat numberMetabolism disorderGenetic material ingredientsMammalGenotype
The invention relates to methods to select animals, such as mammals, in particular, domestic animals such as breeding animals or animals destined for slaughter, for having desired genotypic or potential phenotypic properties, in particular, related to muscle mass and / or fat deposition or, in the case of mammals, to teat number. The invention provides a method for selecting an animal for having desired genotypic or potential phenotypic properties comprising testing the animal, a parent of the animal or its progeny for the presence of a nucleic acid modification affecting the activity of an evolutionary conserved CpG island, located in intron 3 of an IGF2 gene and / or for the presence of a nucleic acid modification affecting binding of a nuclear factor to an IGF2 gene.
Owner:LEIGE UNIV OF +3
Compositions and methods for controlling the weight of animals
Owner:HILLS PET NUTRITION INC
Methods for enhancing the quality of life of a senior animal
Owner:HILLS PET NUTRITION INC
Nutritional composition for the stimulation of muscle protein synthesis
ActiveCN103079415AGood for healthImprove exercise effectOrganic active ingredientsVitamin food ingredientsMuscle strengthMammal
The invention relates to the use of an anabolic amino acid derivative stimulus acting in combination with vitamin D for the manufacture of a medicament or nutritional composition for the prevention and / or treatment of a loss of any one of muscle mass, muscle strength, muscle function, and physical function, or any combination thereof, in a mammal.
Owner:NUTRICIA
Nutritional composition
InactiveUS20140044828A1Promote recoveryIncrease muscle massVitamin food ingredientsHydroxy compound active ingredientsAcute hyperglycaemiaLow body temperature
A nutritional composition is provided which has an effective prophylactic and / or improving effect for various symptoms of muscle mass decrease, decreased basal metabolism, low body temperature, suppression of obesity, suppression of visceral fat accumulation, hyperglycemia, hyperlipidemia and the like in elderly people. The nutritional composition can include n-3 fatty acid and one or more of free lysine, dipeptides containing lysine, and lysine salts, wherein the content of free lysine, dipeptides containing lysine, and / or lysine salts is 0.1 g-10.0 g per 100 kcal of the composition, and the content of the total amount of n-3 fatty acid is 0.17 g-5.00 g per 100 kcal of the composition.
Owner:AJINOMOTO CO INC
Methods and apparatuses to effect deformation of computer-generated three-dimensional surfaces
Embodiments of the invention provide methods and systems to deform a computer-generated three-dimensional surface using a lattice of rigid bone segments driven by an interpolation algorithm to define a muscle. Such embodiments allow a realistic presentation of subdermal muscle mass. In one embodiment, each end of a curve, created by an interpolation function, is attached to a corresponding bone. One or more muscle segments are attached along the curve. The curve along with the attached muscle segments defines a muscle. As the bones move and rotate the curve is expanded or contracted due to the endpoints of the curve being fixed to distinct bones. The attached muscle segments will experience corresponding expansion and contraction thus providing a realistic presentation of skin deformation. For one embodiment, the position of each muscle segment is determined in reference to a standard Bezier interpolation function.
Owner:AUTODESK INC
Novel Muscle Growth Regulator
InactiveUS20080051328A1Treatment prophylaxisImprove muscle massOrganic active ingredientsPeptide/protein ingredientsDiseaseFactor ii
A muscle growth regulating factor includes polynucleotide and polypeptide sequences, promoter sequences, constructs comprising the sequences, and compositions for regulating muscle growth and treating diseases associated with muscle growth. The present sequences can be used in identifying animals with altered muscle mass, and for selective breeding programs to produce animals with altered muscle mass.
Owner:ORICO
Compositions and methods for increasing lean muscle mass and/or reducing fat gain
ActiveUS8071122B2Reducing fat gainQuality improvementMetabolism disorderMuscular disorderArginineTert-leucine
Compositions and methods for increasing lean muscle mass and / or reducing fat gain in growing animals by feeding the animals a composition having a total lysine to metabolizable energy ratio of from about 2.5 to about 6 g / Mcal and comprising (a) arginine in a total arginine to total lysine ratio of from about 1.1 to about 1.6; (b) isoleucine in a total isoleucine to total lysine ratio of from about 0.8 to about 1.3; (c) leucine in a total leucine to total lysine ratio of from about 1.8 to about 3.0; (d) valine in a total valine to total lysine ratio of from about 0.8 to about 1.4; and (e) methionine and cystine in a total methionine plus cystine to total lysine ratio of from about 0.8 to about 1.7.
Owner:HILLS PET NUTRITION INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com